April 9, 2023

Strength training reduces BP when practiced with moderate to vigorous intensity two or three times a week

Strength training practiced with moderate to vigorous intensity two or three times a week is an effective way to mitigate arterial hypertension (high blood pressure), according to a Brazilian study described in an article published in the journal Scientific Reports. The mechanisms behind the lowering of blood pressure by aerobic exercise are well studied, but little research has been done on the effects […]

admin Health 0 3 min read
November 4, 2022

Nifedipine effective for stabilizing blood pressure during induction of labor in women with preeclampsia

Pregnant women with severe preeclampsia taking a daily dose of blood pressure lowering nifedipine as labor is induced have achieved better blood pressure control during labor and were less likely to require fast-acting treatments to lower very high blood pressure. Researchers reported these findings on October 3, 2022 in Hypertension. “We know that bringing down very high blood pressure to […]

admin Health 0 1 min read
February 11, 2022

When it comes to obesity, the problem isn’t an excess of fat but its loss of function, researchers argue

Obesity is known to cause cardiometabolic diseases like hypertension and diabetes but attributing these diseases to merely an overabundance of fat is a simplification. On a basic level, fat acts as a receptacle to store energy, but upon a closer look it is an essential actor in vital bodily processes like the immune response, the regulation of insulin sensitivity, and […]

admin Health 0 1 min read
April 12, 2021

New real-world observational analysis of Uptravi underscores the importance of risk assessment for treating pulmonary arterial hypertension patients -Johnson & Johnson

Findings from an analysis of the first 500 patients enrolled in the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry) found more than three-quarters (76%) of pulmonary arterial hypertension (PAH) patients treated with Uptravi (selexipag)from Johnson & Johnson, either maintained (56%) or reduced (20%) their one-year mortality risk score. The SPHERE results were published in the April issue of the Journal […]

admin Health 0 3 min read

Archives

Categories

Meta

Recent Posts

Recent Comments